Is Takeda Pharmaceutical Company Limited (TAK) one of the best healthcare stocks to buy for 2026?

Takeda Pharmaceutical Company Limited (NYSE:TAK) is one of the best healthcare stocks to buy for 2026. Takeda Pharmaceutical ...
PE Hub

Platinum Equity makes investment in TAK Communications

TAK’s owners and management retained a significant ownership stake TAK was founded in 2004 by CEO Micah Mauney Platinum Equity has approximately $47bn of assets under management Platinum Equity ...
Business Wire

Takeda’s TAK-861 Phase 2b Late-Breaking Data Presentations at SLEEP 2024 Demonstrate Clinically Meaningful Impact of Oral Orexin Agonist in Narcolepsy Type 1 Compared to Placebo

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE: 4502/NYSE:TAK) will present today positive results from its Phase 2b trial of TAK-861 in narcolepsy type 1 (NT1) as late-breaking data ...

Takeda Advances TAK-861 Into Phase 3 for Narcolepsy With Cataplexy, Setting Up a New CNS Catalyst

Detailed price information for Takeda Pharmaceutical Ltd ADR (TAK-N) from The Globe and Mail including charting and trades.
Nasdaq

TAK Quantitative Stock Analysis

Below is Validea's guru fundamental report for TAKEDA PHARMACEUTICAL CO LTD (ADR) (TAK). Of the 22 guru strategies we follow, TAK rates highest using our Twin Momentum Investor model based on the ...